IP Verse

Improved Media For The Expression Of Recombinant Vitamin K-Dependent Proteins - EP3383894

The patent EP3383894 was granted to CSL Behring Lengnau on May 6, 2020. The application was originally filed on Dec 2, 2016 under application number EP16806055A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3383894

CSL BEHRING LENGNAU
Application Number
EP16806055A
Filing Date
Dec 2, 2016
Status
Granted And Under Opposition
Apr 3, 2020
Grant Date
May 6, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

WALLINGER RICKER SCHLOTTER TOSTMANNFeb 5, 2021KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORFADMISSIBLE

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTEP1816201
INTERNATIONAL-SEARCH-REPORTWO0229045
INTERNATIONAL-SEARCH-REPORTWO2006101474
INTERNATIONAL-SEARCH-REPORTWO2007003640
INTERNATIONAL-SEARCH-REPORTWO2007036291
INTERNATIONAL-SEARCH-REPORTWO2007075976
INTERNATIONAL-SEARCH-REPORTWO2011003153
OPPOSITIONUS2007212770
OPPOSITIONUS8785194
OPPOSITIONWO03029442
OPPOSITIONWO2004024899
OPPOSITIONWO2005035748
OPPOSITIONWO2006089613
OPPOSITIONWO2006101474
OPPOSITIONWO2007036291
OPPOSITIONWO2007075976
OPPOSITIONWO2011003153
OPPOSITIONWO2014110433
OPPOSITIONWO2017093482

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Coaset Factor FVII", Chromogenix, (000000), page 1, XP055786626-
OPPOSITION- Anonymous, "Schneider's Insect Medium", SIGMA-ALDRICH, (20140000), pages 1 - 2, XP055786620-
OPPOSITION- Berg J.M., Tymoczko J.L., Stryer L., "Section 17.1 The Citric Acid Cycle Oxidizes Two-Carbon Units", Biochemistry, New York, (20020000), pages 1 - 12, XP055786622-
OPPOSITION- Lee Jung Ja, Michael J. Fasco, "Metabolism of Vitamin K and Vitamin K 2,3- Epoxide via interaction with a common Disulfide", Biochemistry, (19840000), vol. 23, no. 10, pages 2246 - 52, XP055786614-
OPPOSITION- NILSANG et al., "Effect of £X-Keto«lutarate on Monoclonal AntibodyProduction of Hybridoma Cell Lines in Seruni-Ereeand Serum-Contain.ing Medium", Applied Biochemistry and Biotechnology, (20080812), vol. 151, no. 2-3, pages 489 - 501, XP055786613-
OPPOSITION- Soute Berry A.M., Monique M.C. L. Groenen-Van Dooren, Arne Holmgren, Johanna Lundstrom, Gees Vermeer, "Stimulation of the dithiol-dependent reductases in the vitamin K cycle by the thioredoxin system", The Biochemical Journal, (19920000), vol. 281, pages 255 - 259, XP055786618-
OPPOSITION- Vatandoost Jafar, A. Zomorodipour, M. Sadeghizadeh, R. Aliyari, M. H. A. Bos, F. Ataei, "Expression of Biologically Active Human Clotting Factor IX in Drosophila S2 Cells: y-Carboxylation of a Human Vitamin K-Dependent Protein by the InsectEnzyme", AICHE (American Institute of Chemical Engineers), (20111019), vol. 28, no. 1, pages 45 - 51, XP055786610-
OPPOSITION- WALLIN R., Louis F, MARTIN, "Warfarin poisoning and vitamin K antagonism in rat and human liver", The Biochemical Journal, (19870000), vol. 241, pages 389 - 396, XP055786619-
OPPOSITION- YUN ZHANYOU et al., "Combined addition of glutathione and iron chelators for decrease of intracellular level of reactive oxygen species and death of Chinese hamster ovary cells.", Journal of bioscience and bioengineering, NL , (20030201), vol. 95, no. 2, ISSN 1389-1723, pages 124 - 127, XP002351652-
OPPOSITION- Derouazi, M. Martinet, D. Besuchet Schmutz, N. Flaction, R. Wicht, M. Bertschinger, M. Hacker, D.L. Beckmann, J.S. Wurm, F.M., "Genetic characterization of CHO production host DG44 and derivative recombinant cell lines", Biochemical and Biophysical Research Communications, Amsterdam NL , (20060224), vol. 340, no. 4, doi:10.1016/j.bbrc.2005.12.111, ISSN 0006-291X, pages 1069 - 1077, XP005242991
OPPOSITION- YUN Z, TAKAGI M, YOSHIDA T, "EFFECT OF ANTIOXIDANTS ON THE APOPTOSIS OF CHO CELLS AND PRODUCTION OF TISSUE PLASMINOGEN ACTIVATOR IN SUSPENSION CULTURE.", Journal of bioscience and bioengineering, NL , (20010101), vol. 91, no. 6, doi:10.1263/jbb.91.581, ISSN 1389-1723, pages 581 - 585, XP003009916

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents